GO:0006000 fructose metabolic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006000 fructose metabolic process describes all chemical reactions and pathways involving fructose, a ketohexose that exists in open-chain or ring forms and is the sweetest natural sugar.
• Dietary fructose is metabolized primarily in the small intestine, liver, and kidney, with the small intestine converting much of it to glucose and organic acids before it reaches the liver.
• Fructose metabolism bypasses the phosphofructokinase regulatory step of glycolysis, allowing unregulated carbon flux into de novo lipogenesis and contributing to fatty liver disease and metabolic syndrome.
• Key enzymes include ketohexokinase (KHK), aldolase B (ALDOB), and fructose-1,6-bisphosphatase (FBP1), which are critical for fructose clearance and gluconeogenesis.
• Cancer cells can exploit fructose metabolism to support proliferation, and KHK and ALDOB expression is altered in several tumor types.
• CRISPR-based knockout, knock-in, and overexpression models of KHK, ALDOB, and GLUT5 are essential tools for dissecting fructose metabolic process in health and disease.
Description
Fructose metabolic process (GO:0006000) encompasses the biochemical reactions and pathways that convert fructose, a ketohexose sugar, into intermediates used for energy production, gluconeogenesis, and lipogenesis. Fructose is found free in fruits and honey and is a major component of modern diets through sucrose and high-fructose corn syrup. Unlike glucose, fructose enters cells via specific transporters such as GLUT5 (SLC2A5) and is phosphorylated by ketohexokinase (KHK) to fructose-1-phosphate, bypassing the regulatory step catalyzed by phosphofructokinase in glycolysis. This unregulated entry makes fructose a potent substrate for hepatic de novo lipogenesis and a contributor to metabolic disorders. Understanding fructose metabolic process is critical for researchers studying obesity, type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), and cancer metabolism. The small intestine plays a major role in fructose clearance, converting dietary fructose into glucose and organic acids before it reaches the liver, which reshapes our understanding of whole-body fructose handling. In clinical nutrition, fructose is used as a sweetener for diabetic patients, but its metabolic effects require careful evaluation. This article integrates authoritative QuickGO annotation data with published literature to provide a research-grade overview of fructose metabolic process, its key genes, regulatory mechanisms, disease links, and experimental models including CRISPR-based approaches.
fructose metabolic process At A Glance
| GO ID | GO:0006000 |
|---|---|
| GO term | fructose metabolic process |
| Ontology | biological_process |
| Synonym | fructose metabolism |
| Definition | The chemical reactions and pathways involving fructose, the ketohexose arabino-2-hexulose. Fructose exists in an open chain form or as a ring compound. D-fructose is the sweetest of the sugars and is found free in a large number of fruits and honey. |
| Major function | Conversion of fructose into intermediates for energy production, gluconeogenesis, and lipogenesis |
| Key enzymes | KHK, ALDOB, FBP1, GLUT5 (SLC2A5) |
| Subcellular location | Cytosol, endoplasmic reticulum, mitochondria (partially) |
| Related pathways | Glycolysis, gluconeogenesis, pentose phosphate pathway, de novo lipogenesis |
What Is GO:0006000?
GO:0006000 fructose metabolic process is defined as the chemical reactions and pathways involving fructose, the ketohexose arabino-2-hexulose. Fructose exists in an open chain form or as a ring compound, and D-fructose is the sweetest of the sugars and is found free in a large number of fruits and honey. This biological process includes the transport, phosphorylation, cleavage, and interconversion of fructose and its phosphorylated derivatives, as well as its integration into glycolysis, gluconeogenesis, and lipogenesis.
Why Is fructose metabolic process Important in Cell Biology?
Fructose metabolic process is central to human health because excessive dietary fructose is strongly linked to metabolic syndrome, fatty liver disease, insulin resistance, and obesity. The unique ability of fructose to bypass the phosphofructokinase regulatory checkpoint drives unregulated hepatic de novo lipogenesis, contributing to hepatic steatosis and dyslipidemia. In cancer, fructose metabolism supports tumor growth and proliferation, making it a potential therapeutic target. In clinical nutrition, fructose is used as a sweetener for diabetic patients, but its metabolic consequences require careful monitoring. Thus, understanding fructose metabolic process is essential for developing interventions against metabolic and neoplastic diseases.
• Fructose is a major dietary sugar linked to non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome.
• Fructose metabolism bypasses the phosphofructokinase step, promoting unregulated de novo lipogenesis.
• The small intestine clears much of dietary fructose, converting it to glucose and organic acids before it reaches the liver.
• Fructose metabolism is reprogrammed in cancer cells to support proliferation and survival.
• Ketohexokinase (KHK) and aldolase B (ALDOB) are key enzymes whose dysfunction causes hereditary fructose intolerance.
• Fructose is used in clinical nutrition for diabetic patients, but its metabolic effects require evaluation.
• Fructose metabolism intersects with gluconeogenesis and the pentose phosphate pathway, influencing whole-body glucose homeostasis.
• CRISPR models of fructose metabolic genes enable causal testing of their roles in disease.
What Happens During fructose metabolic process?
Fructose uptake and transport
In simple terms: Fructose enters cells through specific doorways called transporters.
Dietary fructose is absorbed in the small intestine primarily via the facilitative transporter GLUT5 (SLC2A5) and to a lesser extent GLUT2. In the small intestine, fructose is taken up by enterocytes and can be converted to glucose and organic acids such as lactate and acetate before entering the portal circulation. This first-pass metabolism limits the amount of fructose reaching the liver and systemic circulation. In the liver, fructose is transported by GLUT2 and GLUT5, while in kidney and adipose tissue, specific transporters mediate uptake.
Phosphorylation by ketohexokinase (KHK)
In simple terms: Fructose is tagged with a phosphate group by the enzyme KHK, trapping it inside the cell.
Once inside the cell, fructose is phosphorylated to fructose-1-phosphate by ketohexokinase (KHK, also known as fructokinase) in an ATP-dependent reaction. This step bypasses the regulatory enzyme phosphofructokinase, which controls glycolytic flux for glucose. KHK exists in two isoforms, KHK-A and KHK-C, with KHK-C having higher affinity for fructose and being predominantly expressed in liver, kidney, and small intestine. The unregulated activity of KHK leads to rapid depletion of ATP and phosphate, contributing to cellular stress and uric acid production.
Cleavage by aldolase B (ALDOB)
In simple terms: The tagged fructose is split into two smaller molecules by aldolase B.
Fructose-1-phosphate is cleaved by aldolase B (ALDOB) into dihydroxyacetone phosphate (DHAP) and glyceraldehyde. DHAP enters glycolysis, while glyceraldehyde is phosphorylated by triokinase to glyceraldehyde-3-phosphate, which also enters glycolysis. This cleavage step is essential for fructose metabolism, and deficiency of ALDOB causes hereditary fructose intolerance, a condition characterized by severe hypoglycemia and liver damage upon fructose ingestion.
Integration into glycolysis and gluconeogenesis
In simple terms: The split products feed into the same energy-producing pathways as glucose.
The triose phosphates derived from fructose enter glycolysis, producing pyruvate, acetyl-CoA, and citrate. In the liver, fructose carbons can also be used for gluconeogenesis, contributing to glucose production. The rapid flux of fructose carbons into acetyl-CoA and citrate provides substrates for de novo lipogenesis, a key mechanism linking fructose consumption to fatty liver disease.
De novo lipogenesis and metabolic consequences
In simple terms: Excess fructose is converted into fat, which can accumulate in the liver.
Fructose metabolism provides acetyl-CoA and glycerol-3-phosphate for de novo lipogenesis, leading to increased triglyceride synthesis and very-low-density lipoprotein (VLDL) secretion. This process is mediated by transcription factors such as SREBP-1c and ChREBP, which are activated by fructose metabolites. Chronic fructose overconsumption promotes hepatic steatosis, insulin resistance, and dyslipidemia, contributing to metabolic syndrome.
Fructose metabolism in cancer
In simple terms: Cancer cells can use fructose to grow faster.
Cancer cells often upregulate fructose transporters and enzymes such as GLUT5, KHK, and ALDOB to support their metabolic demands. Fructose can be used to generate ribose-5-phosphate for nucleotide synthesis via the pentose phosphate pathway, and to produce NADPH for redox balance. In some cancers, KHK-A (the low-affinity isoform) promotes nucleic acid synthesis and tumor growth, while KHK-C is more active in lipogenesis. Targeting fructose metabolism is being explored as a therapeutic strategy in oncology.
Key Genes Involved in GO:0006000 fructose metabolic process
The following genes and proteins are central to fructose metabolic process, based on published literature and QuickGO annotations.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KHK | Phosphorylates fructose to fructose-1-phosphate | Key enzyme in fructose clearance; knockout models show protection from fatty liver |
| ALDOB | Cleaves fructose-1-phosphate into DHAP and glyceraldehyde | Deficiency causes hereditary fructose intolerance; knockout models mimic disease |
| SLC2A5 (GLUT5) | Facilitative fructose transporter | Mediates fructose uptake in intestine, kidney, and cancer cells |
| SLC2A2 (GLUT2) | Bidirectional glucose/fructose transporter | Facilitates fructose transport in liver and kidney |
| FBP1 | Fructose-1,6-bisphosphatase, gluconeogenesis | Regulates fructose-derived gluconeogenesis; loss linked to cancer |
| GCK | Glucokinase, phosphorylates glucose | Indirectly affects fructose metabolism via glucose/fructose interconversion |
| PFKL | Phosphofructokinase, liver isoform | Regulates glycolysis downstream of fructose entry |
| TRIOKINASE (TKFC) | Phosphorylates glyceraldehyde to glyceraldehyde-3-phosphate | Essential for fructose carbon entry into glycolysis |
| SREBF1 | Transcription factor for lipogenic genes | Mediates fructose-induced de novo lipogenesis |
| MLXIPL (ChREBP) | Transcription factor for lipogenic genes | Activated by fructose metabolites to drive lipogenesis |
| ACACA | Acetyl-CoA carboxylase, lipogenesis | Upregulated by fructose metabolism |
| FASN | Fatty acid synthase, lipogenesis | Upregulated by fructose metabolism |
| SCD | Stearoyl-CoA desaturase, lipogenesis | Upregulated by fructose metabolism |
| PKLR | Pyruvate kinase, liver and RBC | Regulates glycolytic flux from fructose |
| LDHA | Lactate dehydrogenase A | Converts fructose-derived pyruvate to lactate |
| PC | Pyruvate carboxylase, gluconeogenesis | Uses fructose-derived pyruvate for glucose production |
| G6PC | Glucose-6-phosphatase, gluconeogenesis | Final step of gluconeogenesis from fructose |
How Is fructose metabolic process Regulated?
Fructose metabolic process is regulated at multiple levels. The transcription factors SREBP-1c and ChREBP are activated by fructose metabolites and drive expression of lipogenic genes such as ACACA, FASN, and SCD. KHK activity is regulated by its substrate availability and by ATP/ADP ratios, and the KHK-A isoform can be regulated by phosphorylation. In the small intestine, fructose transport and metabolism are regulated by dietary intake and hormonal signals. Additionally, fructose metabolism intersects with insulin signaling and the mTOR pathway, which can modulate lipogenesis and cell growth.
fructose metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KHK | NAFLD, metabolic syndrome | KHK knockout mouse; hepatocyte-specific KO |
| ALDOB | Hereditary fructose intolerance | ALDOB knockout or point-mutation knock-in mice |
| SLC2A5 (GLUT5) | Cancer, fructose absorption | GLUT5 knockout or overexpression in cancer cell lines |
| SREBF1 | NAFLD, dyslipidemia | Liver-specific SREBP-1c knockout or overexpression |
| MLXIPL (ChREBP) | NAFLD, insulin resistance | ChREBP knockout mice |
Fructose metabolic process and non-alcoholic fatty liver disease (NAFLD)
Excessive fructose consumption is a major driver of NAFLD through unregulated de novo lipogenesis, leading to hepatic steatosis, inflammation, and fibrosis. Fructose metabolism depletes ATP and generates uric acid, which further promotes oxidative stress and lipogenesis. KHK knockout mice are protected from fructose-induced fatty liver, demonstrating a causal role.
Fructose metabolic process and metabolic syndrome
Dietary fructose contributes to metabolic syndrome by promoting insulin resistance, dyslipidemia, hypertension, and obesity. Fructose-induced lipogenesis and uric acid production are key mechanisms. Clinical studies show that high fructose intake worsens metabolic parameters in susceptible individuals.
Fructose metabolic process and cancer
Cancer cells reprogram fructose metabolism to support proliferation, with upregulation of GLUT5, KHK, and ALDOB in several tumor types. Fructose provides carbons for nucleotide synthesis and NADPH production, and KHK-A promotes tumor growth in some contexts. Targeting fructose metabolic enzymes is a potential therapeutic strategy.
Fructose metabolic process and hereditary fructose intolerance
Mutations in ALDOB cause hereditary fructose intolerance, a rare autosomal recessive disorder characterized by severe hypoglycemia, vomiting, and liver failure upon fructose ingestion. Diagnosis is confirmed by genetic testing, and treatment involves strict avoidance of fructose and sucrose.
From fructose metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does KHK loss protect against fructose-induced fatty liver? | KHK knockout mouse or hepatocyte-specific KO |
| Does ALDOB deficiency cause hereditary fructose intolerance? | ALDOB point-mutation knock-in mouse |
| Does GLUT5 overexpression increase fructose uptake in cancer? | GLUT5 overexpression in cancer cell lines |
| Does ChREBP mediate fructose-induced lipogenesis? | ChREBP knockout mouse or CRISPR KO in hepatocytes |
| Does fructose metabolism contribute to gluconeogenesis? | FBP1 or PC knockout in liver cells |
| Can fructose metabolism be targeted in cancer? | KHK or ALDOB knockout in cancer xenografts |
How to Study the fructose metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C-fructose tracing | Metabolic flux of fructose carbons | Quantify lipogenesis and gluconeogenesis |
| RNA-seq | Transcriptional changes | Identify fructose-regulated genes |
| Proteomics | Protein abundance and modifications | Measure enzyme levels in fructose metabolism |
| Metabolomics | Metabolite concentrations | Quantify fructose-1-phosphate, DHAP, etc. |
| CRISPR knockout screening | Gene essentiality for fructose phenotypes | Discover novel regulators of fructose metabolism |
| Western blot | Protein expression and phosphorylation | Validate KHK, ALDOB, SREBP-1c expression |
| Reporter assays | Promoter activity of lipogenic genes | Test ChREBP/SREBP-1c activation by fructose |
Metabolic flux analysis
Isotope tracing with 13C-labeled fructose combined with mass spectrometry measures fructose carbon flux into glycolysis, gluconeogenesis, and lipogenesis. This method quantifies the contribution of fructose to specific metabolic pathways in cells and animal models.
Transcriptomics and RNA-seq
RNA sequencing of cells or tissues treated with fructose reveals changes in gene expression, including upregulation of lipogenic genes such as SREBF1, ACACA, and FASN. This approach identifies transcriptional programs regulated by fructose metabolism.
Proteomics and metabolomics
Mass spectrometry-based proteomics and metabolomics quantify enzyme abundance and metabolite levels in fructose metabolism, such as fructose-1-phosphate, DHAP, and glyceraldehyde-3-phosphate. These methods provide a systems-level view of pathway activity.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes required for fructose metabolism and fructose-induced phenotypes, such as lipogenesis or cell proliferation. Hits from screens can be validated with individual knockout models.
How CRISPR Can Be Used to Study GO:0006000 fructose metabolic process
Knockout
CRISPR knockout of KHK, ALDOB, or GLUT5 in cell lines and animal models ablates fructose metabolism, allowing researchers to test causal roles in lipogenesis, gluconeogenesis, and disease phenotypes. For example, KHK knockout mice are protected from fructose-induced fatty liver.
Point Mutation
CRISPR point mutation can introduce disease-relevant mutations, such as ALDOB mutations causing hereditary fructose intolerance, to study enzyme function and disease mechanisms. Point mutations in KHK can dissect isoform-specific functions.
Knock-in
CRISPR knock-in of tagged or reporter alleles (e.g., GFP-KHK) enables visualization and tracking of fructose metabolic enzymes in live cells and tissues. Knock-in of human disease alleles into mouse models facilitates translational research.
Overexpression
CRISPR-mediated overexpression of GLUT5, KHK, or ALDOB in cell lines increases fructose uptake and metabolism, mimicking cancer or metabolic disease states. Overexpression models help identify downstream effects on proliferation and lipogenesis.
How EDITGENE Supports fructose metabolic process Research
Researchers studying fructose metabolic process-related genes often need to determine whether a candidate gene is causally involved in fructose handling, lipogenesis, or disease progression. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional studies of fructose metabolism.
Contact EDITGENE today to design your custom CRISPR model for fructose metabolic process research.
Frequently Asked Questions About fructose metabolic process
What is fructose metabolic process?
Fructose metabolic process (GO:0006000) is the set of chemical reactions and pathways involving fructose, including its transport, phosphorylation, cleavage, and integration into glycolysis, gluconeogenesis, and lipogenesis.
What genes are involved in fructose metabolic process?
Key genes include KHK, ALDOB, SLC2A5 (GLUT5), SLC2A2 (GLUT2), FBP1, and lipogenic transcription factors SREBF1 and MLXIPL (ChREBP).
How is fructose metabolized in the liver?
In the liver, fructose is transported by GLUT2/GLUT5, phosphorylated by KHK to fructose-1-phosphate, cleaved by ALDOB into DHAP and glyceraldehyde, and then enters glycolysis or lipogenesis.
What is the role of ketohexokinase (KHK) in fructose metabolism?
KHK phosphorylates fructose to fructose-1-phosphate, bypassing the regulatory step of glycolysis and driving unregulated fructose flux into lipogenesis.
How does fructose contribute to fatty liver disease?
Fructose metabolism provides acetyl-CoA and glycerol for de novo lipogenesis, leading to triglyceride accumulation and hepatic steatosis.
What is hereditary fructose intolerance?
Hereditary fructose intolerance is a rare disease caused by ALDOB mutations, leading to severe hypoglycemia and liver damage upon fructose ingestion.
Can fructose metabolism be targeted in cancer?
Yes, cancer cells upregulate fructose transporters and enzymes such as GLUT5 and KHK, and targeting these may inhibit tumor growth.
What experimental models are used to study fructose metabolism?
Models include KHK and ALDOB knockout mice, GLUT5 overexpression cell lines, and CRISPR screens in hepatocytes and cancer cells.
How does the small intestine handle dietary fructose?
The small intestine converts much of dietary fructose into glucose and organic acids before it reaches the liver, limiting systemic fructose exposure.
What methods measure fructose metabolic flux?
13C-fructose tracing with mass spectrometry, metabolomics, and RNA-seq are commonly used to measure fructose metabolism.
Conclusion
Fructose metabolic process (GO:0006000) is a fundamental biological pathway with profound implications for metabolic health and disease. The unique biochemistry of fructose, including its bypass of glycolytic regulation, makes it a potent driver of de novo lipogenesis and a contributor to NAFLD, metabolic syndrome, and cancer. Understanding the genes, enzymes, and regulatory mechanisms of fructose metabolism is essential for developing targeted therapies. CRISPR-based models from EDITGENE provide powerful tools to dissect these mechanisms and accelerate translational research.
References
- 1. Softic S et al.. 2016. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.. Dig Dis Sci 61(5):1282-93 PMID: 26856717
- 2. Jang C et al.. 2018. The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids.. Cell Metab 27(2):351-361.e3 PMID: 29414685
- 3. Lê KA et al.. 2006. Metabolic effects of fructose.. Curr Opin Clin Nutr Metab Care 9(4):469-75 PMID: 16778579
- 4. Taskinen MR et al.. 2019. Dietary Fructose and the Metabolic Syndrome.. Nutrients 11(9) PMID: 31443567
- 5. Baharuddin B. 2025. The metabolic and molecular mechanisms linking fructose consumption to lipogenesis and metabolic disorders.. Clin Nutr ESPEN 69:63-68 PMID: 40578484
- 6. Krause N et al.. 2020. Fructose Metabolism in Cancer.. Cells 9(12) PMID: 33302403
- 8. Moulin S et al.. 2017. Fructose use in clinical nutrition: metabolic effects and potential consequences.. Curr Opin Clin Nutr Metab Care 20(4):272-278 PMID: 28383298
